The FDA has rescinded the marketing denial orders (MDOs) issued to JUUL Labs Inc., returning the applications to pending status. This decision follows new case law and additional information provided by JUUL. The FDA continues its review of JUUL's applications, which must be authorized to be legally marketed. The rescission comes after the FDA's updated understanding of e-cigarette products and recent litigation outcomes. JUUL, which owns 41% of the $21.63 billion e-cigarette market, had faced a potential ban and financial difficulties.